Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | LNPEP | Q9UIQ6 | 7/20 | 0.36 |
| ▸ | ERAP2 | Q6P179 | 7/20 | 0.36 |
| ▸ | ERAP1 | Q9NZ08 | 3/20 | 0.36 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.35 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | TERT | O14746 | 4/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13820103 | 1.00 | LTA4H (0.41) | LTA4HMMP2LNPEPERAP2ERAP1 | |
| Hydrochloric Acid SCHEMBL13716978 | 0.99 | LTA4H (0.40) | LTA4HMMP2LNPEPERAP2ERAP1 | |
| Hydrochloric Acid SCHEMBL13716979 | 0.99 | LTA4H (0.40) | LTA4HMMP2LNPEPERAP2ERAP1 | |
| SCHEMBL13820117 | 0.93 | LTA4H (0.38) | LTA4HMMP2LNPEPERAP2ERAP1 | |
| Hydrochloric Acid SCHEMBL13717647 | 0.92 | LTA4H (0.37) | LTA4HMMP2LNPEPERAP2ERAP1 | |
| SCHEMBL13820101 | 0.88 | L3MBTL1 (0.34) | L3MBTL1 | |
| SCHEMBL13827711 | 0.81 | LTA4H (0.43) | LTA4HMMP2LNPEPERAP2ERAP1 | |
| SCHEMBL13827493 | 0.81 | LTA4H (0.43) | LTA4HMMP2LNPEPERAP2ERAP1 | |
| SCHEMBL13820179 | 0.80 | LTA4H (0.44) | LTA4HMMP2TERT | |
| SCHEMBL13820111 | 0.80 | LTA4H (0.44) | LTA4HMMP2TERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8927728-B2 | Dipeptide acetylene conjugates and a method for photocleavage of double strand DNA by dipeptide acetylene conjugates | The Florida State University Research Foundation, Inc. (US) | 2015-01-06 | — | — | US | disclosed |
| US-8927728-B2 | Dipeptide acetylene conjugates and a method for photocleavage of double strand DNA by dipeptide acetylene conjugates | The Florida State University Research Foundation, Inc. (US) | 2015-01-06 | — | — | US | disclosed |
| US-20120288940-A1 | DIPEPTIDE ACETYLENE CONJUGATES AND A METHOD FOR PHOTOCLEAVAGE OF DOUBLE STRAND DNA BY DIPEPTIDE ACETYLENE CONJUGATES | The Florida State University Research Foundation, Inc. (US) | 2012-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120288940-A1 | DIPEPTIDE ACETYLENE CONJUGATES AND A METHOD FOR PHOTOCLEAVAGE OF DOUBLE STRAND DNA BY DIPEPTIDE ACETYLENE CONJUGATES | DNPEP, DCLRE1A, PCNA | LTA4H 3125/4885MMP2 776/4885LNPEP 35/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.